VFA
Voya Financial Advisors Portfolio holdings
AUM
$991M
1-Year Return
11.78%
This Quarter Return
+1.47%
1 Year Return
+11.78%
3 Year Return
+36.54%
5 Year Return
+51.86%
10 Year Return
+123.39%
AUM
$1.86B
AUM Growth
-$14.4M
(-0.77%)
Cap. Flow
-$39.3M
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
35.29%
Holding
645
New
31
Increased
322
Reduced
234
Closed
35
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$22.7M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
$17.2M |
| 3 |
Vanguard Total Bond Market
BND
|
$7.2M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$6M |
| 5 |
Vanguard Large-Cap ETF
VV
|
$4.69M |
Top Sells
Sector Composition
| 1 | Financials | 6.56% |
| 2 | Healthcare | 5.61% |
| 3 | Technology | 5.32% |
| 4 | Consumer Discretionary | 4.35% |
| 5 | Communication Services | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
International Flavors & Fragrances
IFF
$16.9B
| $355K | 0.02% |
2,942
+266
| +10% | +$32.1K |
|
452
Nucor
NUE
$33.8B
| $354K | 0.02% |
7,078
-2,242
| -24% | -$112K |
|
453
Mercado Libre
MELI
$123B
| $352K | 0.02% |
650
-53
| -8% | -$28.7K |
|
454
Delta Air Lines
DAL
$39.9B
| $351K | 0.02% |
6,028
-855
| -12% | -$49.8K |
|
455
Check Point Software Technologies
CHKP
$20.7B
| $350K | 0.02% |
3,234
+82
| +3% | +$8.87K |
|
456
Cardinal Health
CAH
$35.7B
| $347K | 0.02% |
7,299
-594
| -8% | -$28.2K |
|
457
Core Laboratories
CLB
$592M
| $342K | 0.02% |
7,450
+2,523
| +51% | +$116K |
|
458
Schlumberger
SLB
$53.4B
| $341K | 0.02% |
9,921
+727
| +8% | +$25K |
|
459
AstraZeneca
AZN
$253B
| $340K | 0.02% |
7,510
+265
| +4% | +$12K |
|
460
Galapagos
GLPG
$2.2B
| $340K | 0.02% |
2,212
+97
| +5% | +$14.9K |
|
461
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.4B
| $339K | 0.02% |
5,084
+61
| +1% | +$4.07K |
|
462
Neogen
NEOG
$1.25B
| $338K | 0.02% |
10,352
+938
| +10% | +$30.6K |
|
463
FS Bancorp
FSBW
$321M
| $336K | 0.02% |
13,062
-748
| -5% | -$19.2K |
|
464
Royal Gold
RGLD
$12.2B
| $334K | 0.02% |
2,657
-1,129
| -30% | -$142K |
|
465
Baxter International
BAX
$12.5B
| $329K | 0.02% |
3,834
-51
| -1% | -$4.38K |
|
466
Novo Nordisk
NVO
$245B
| $328K | 0.02% |
12,696
+182
| +1% | +$4.7K |
|
467
SPDR S&P Biotech ETF
XBI
$5.39B
| $327K | 0.02% |
4,275
+12
| +0.3% | +$918 |
|
468
iShares Russell 1000 ETF
IWB
$43.4B
| $323K | 0.02% |
1,976
-72
| -4% | -$11.8K |
|
469
Universal Health Services
UHS
$12.1B
| $320K | 0.02% |
2,182
+61
| +3% | +$8.95K |
|
470
Amcor
AMCR
$19.1B
| $319K | 0.02% |
32,796
+21,641
| +194% | +$210K |
|
471
Rio Tinto
RIO
$104B
| $319K | 0.02% |
6,146
-146
| -2% | -$7.58K |
|
472
Biogen
BIIB
$20.6B
| $318K | 0.02% |
1,381
-268
| -16% | -$61.7K |
|
473
Advanced Micro Devices
AMD
$245B
| $317K | 0.02% |
+11,032
| New | +$317K |
|
474
Badger Meter
BMI
$5.39B
| $317K | 0.02% |
5,890
-186
| -3% | -$10K |
|
475
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.15B
| $316K | 0.02% |
3,976
-72
| -2% | -$5.72K |
|